Bengt Simonsson

18.0k citations

157 papers · 5.5k indexed · 1 hit paper · h-index 35

Impact in

Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Hematology 110
- Chronic Myeloid Leukemia Treatments 61
- Hematopoietic Stem Cell Transplantation 25
- Acute Myeloid Leukemia Research 20
- Multiple Myeloma Research and Treatments 14
Genetics 76
- Chronic Lymphocytic Leukemia Research 71

Co-authors: B Smedmyr (25 shared papers)François Guilhot (8 shared papers)Rüdiger Hehlmann (14 shared papers)Michele Baccarani (11 shared papers)Hans Hagberg (8 shared papers)Gunnar Öberg (26 shared papers)Clas F. R. Källander (7 shared papers)Martin Höglund (13 shared papers)
Journals: Blood (32 papers)European Journal Of Haematology (14 papers)British Journal of Haematology (9 papers)Bone Marrow Transplantation (5 papers)Leukemia Research (4 papers)
Partner nations: Sweden United States Germany

In The Last Decade

Bengt Simonsson

154 papers receiving 5.3k citations

Hit Papers

align trajectories log scale

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet 2009 · 890 citations

Peers

Countries citing papers authored by Bengt Simonsson

Since Specialization

Citations

This map shows the geographic impact of Bengt Simonsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Simonsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Simonsson more than expected).

Fields of papers citing papers by Bengt Simonsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Simonsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Simonsson. The network helps show where Bengt Simonsson may publish in the future.

Co-authors

The 25 scholars most cited alongside Bengt Simonsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bengt Simonsson Line = papers co-authored together Bengt Simonsson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet Journal of Clinical Oncology ·Michele Baccarani, Jörge E. Cortes, Fabrizio Pane, Dietger Niederwieser, Giuseppe Saglio, Jane F. Apperley, Francisco Cervantes, Michael W. Deininger, Aloïs Gratwohl, François Guilhot, Andreas Hochhaus, Mary M. Horowitz, Timothy P. Hughes, Hagop M. Kantarjian, Richard A. Larson, Jerald P. Radich, Bengt Simonsson, Richard T. Silver, John M. Goldman, Rüdiger Hehlmann Hit paper breakdown →	2009	890
2	Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score Blood ·Joerg Hasford, Michele Baccarani, Verena Hoffmann, Joëlle Guilhot, Susanne Saußele, Gianantonio Rosti, François Guilhot, Kimmo Porkka, Gert J. Ossenkoppele, Doris Lindoerfer, Bengt Simonsson, Markus Pfirrmann, Rüdiger Hehlmann	2011	290
3	Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study Blood ·Oliver G. Ottmann, Hervé Dombret, Giovanni Martinelli, Bengt Simonsson, François Guilhot, Richard A. Larson, Giovanna Rege‐Cambrin, Jerald P. Radich, Andreas Hochhaus, Anne Marie Apanovitch, Ashwin Gollerkeri, Steven Coutré	2007	277
4	Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy Leukemia ·Satu Mustjoki, Marja Ekblom, T. Petteri Arstila, Ingunn Dybedal, Pearlie K. Epling‐Burnette, François Guilhot, Henrik Hjorth‐Hansen, Martin Höglund, Panu E. Kovanen, Tuisku Laurinolli, Jane L. Liesveld, Ronald Paquette, Javier Pinilla‐Ibarz, Auvo Rauhala, Neil P. Shah, Bengt Simonsson, Marjatta Sinisalo, Juan Luis Steegmann, Leif Stenke, Kimmo Porkka	2009	229
5	Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia Leukemia ·Markus Pfirrmann, Michele Baccarani, Susanne Saußele, Joëlle Guilhot, Francisco Cervantes, G.J. Ossenkoppele, Verena Hoffmann, Fausto Castagnetti, Joerg Hasford, Rüdiger Hehlmann, Bengt Simonsson	2015	178
6	Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups The Lancet ·Philip B. McGlave, Paolo de Fabritiis, A. B. Deisseroth, John M. Goldman, Michael J. Barnett, Josy Reiffers, Bengt Simonsson, Angelo Michele Carella, Dorothee M. Aeppli	1994	135
7	Epidemiology of chronic myeloid leukaemia: an update Annals of Hematology ·Martin Höglund, Fredrik Sandin, Bengt Simonsson	2015	133
8	Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology Cancer Chemotherapy and Pharmacology ·Moustapha Hassan, Göran Berg, A N Békássy, J Aschan, Hans Ehrsson, Per Ljungman, G. L�nnerholm, B Smedmyr, Adam Taube, Inger Wallin, Bengt Simonsson	1991	129
9	Pharmacokinetic and metabolic studies of high-dose busulphan in adults European Journal of Clinical Pharmacology ·Moustapha Hassan, Göran Berg, Hans Ehrsson, M. Ehrnebo, Inger Wallin, B Smedmyr, T. H. T�tterman, Staffan Eksborg, Bengt Simonsson	1989	119
10	The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma British Journal of Cancer ·J. Simon Gronowitz, Hans Hagberg, Clas F. R. Källander, Bengt Simonsson	1983	116
11	Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia PLoS ONE ·Lisa Christiansson, Stina Söderlund, Emma Svensson, Satu Mustjoki, Mats Bengtsson, Bengt Simonsson, Ulla Olsson‐Strömberg, Angelica Loskog	2013	99
12	Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia Cancer ·Clas F. R. Källander, Bengt Simonsson, Hans Hagberg, J. Simon Gronowitz	1984	95
13	T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease Blood ·TH Totterman, Maria Carlsson, Bengt Simonsson, Mats Bengtsson, Kristina Nilsson	1989	84
14	Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry Blood ·Martin Höglund, Fredrik Sandin, Karin Hellström, Mats Björeman, Magnus Björkholm, Mats Brune, Arta Dreimane, Marja Ekblom, Sören Lehmann, Per Ljungman, Claes Malm, Berit Markevärn, Kristina Myhr‐Eriksson, Lotta Ohm, Ulla Olsson‐Strömberg, Anders Själander, Hans Wadenvik, Bengt Simonsson, Leif Stenke, Johan Richter	2013	83
15	Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation British Journal of Haematology ·Gunnar Birgegård, Leif Wide, Bengt Simonsson	1989	77
16	Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States JNCI Journal of the National Cancer Institute ·William V. Padula, Richard A. Larson, Stacie B. Dusetzina, Jane F. Apperley, Rüdiger Hehlmann, Michele Baccarani, Ekkehard Eigendorff, Joëlle Guilhot, François Guilhot, François‐Xavier Mahon, Giovanni Martinelli, Jiřı́ Mayer, Martin C. Müller, Dietger Niederwieser, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Rena M. Conti	2016	73
17	Serumβ2-microglobulin in malignant lymphoma Cancer ·Hans Hagberg, A. Killander, Bengt Simonsson	1983	68
18	T regulatory cells control T‐cell proliferation partly by the release of soluble CD25 in patients with B‐cell malignancies Immunology ·Camilla A. Lindqvist, Lisa Christiansson, Bengt Simonsson, Gunilla Enblad, Ulla Olsson‐Strömberg, Angelica Loskog	2010	64
19	STIMULATION OF NK CELL, T CELL, AND MONOCYTE FUNCTIONS BY THE NOVEL IMMUNOMODULATOR LINOMIDE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION Transplantation ·Mats Bengtsson, Bengt Simonsson, KRISTINA CARLSSON, B O NILSSON, B Smedmyr, B. Termander, Gunnar Öberg, THOMAS H. TöTTERMAN	1992	59
20	Magnetic Resonance Imaging in Diffuse Malignant Bone Marrow Diseases Acta Radiologica ·R. Nyman, S Rehn, Bengt Glimelius, Hans Hagberg, A. Hemmingsson, Bo Hyun Jung, Bengt Simonsson, Christer Sundström	1987	58

About Bengt Simonsson

Bengt Simonsson is a scholar working on Hematology, Genetics, Immunology, Pathology and Forensic Medicine and Rheumatology, having authored 157 papers that have together received 5.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (71 papers), Chronic Myeloid Leukemia Treatments (61 papers), Acute Lymphoblastic Leukemia research (27 papers), Hematopoietic Stem Cell Transplantation (25 papers), Lymphoma Diagnosis and Treatment (23 papers), Acute Myeloid Leukemia Research (20 papers), Eosinophilic Disorders and Syndromes (18 papers) and Multiple Myeloma Research and Treatments (14 papers). The work is most often cited by research in Hematology (3.8k citations), Genetics (2.9k citations), Rheumatology (1.4k citations), Pathology and Forensic Medicine (782 citations) and Oncology (1.1k citations). Bengt Simonsson has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include B Smedmyr, François Guilhot, Rüdiger Hehlmann, Michele Baccarani, Hans Hagberg, Gunnar Öberg, Clas F. R. Källander, Martin Höglund, Richard A. Larson and Mats Bengtsson. Their work appears in journals such as Blood, European Journal Of Haematology, British Journal of Haematology, Bone Marrow Transplantation and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact